LETYBO Medical beauty products

1. Brand Introduction Letybo Letybo botulinum toxin is developed by South Korean biopharmaceutical company Hugel and is the largest botulinum toxin product in South Korea. It was introduced to China through exclusive agency by Sihuan Pharmaceuticals. Letibao was officially approved for market by the National Medical Products Administration in October 2020, becoming the fourth type A botulinum toxin approved for market in China and the first and only botulinum toxin product from South Korea in China.       Letybo botulinum toxin has been the sales champion in South Korea for five consecutive years from 2016 to 2020. Why is Letibao botulinum toxin able to maintain the sales champion for five years in such a medical beauty country? Letybo contains 99.5% high-purity 900kDa protein. The protein contained in botulinum toxin is the effective active ingredient that determines botulinum toxin. The higher the protein content, the higher the purity of botulinum t…